ENTROPY NEURODYNAMICS LIMITED — Director's Dealing 2024

Dec 3, 2024

Appendix 3Y Change of Director's Interest Notice

Rule 3.19A.2

Appendix 3Y

Change of Director's Interest Notice

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX becomes ASX's property and may be made public.

Introduced 30/09/01 Amended 01/01/11

Name of entity	Tryptamine Therapeutics Limited
ABN	78 163 765 991

We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.

Name of director	Mark Davies
Date of last notice	3 May 2024

Part 1 - Change of director's relevant interests in securities

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust Note: In the case of a company, interests which come within paragraph (i) of the definition of "notifiable interest of a director" should be disclosed in this part.

Direct or indirect interest	Indirect
Nature of indirect interest(including registered holder)	SEIVAD INVESTMENTS PL <DAVIES FAMILYA/C> Director of Company
Date of change	(1) N/A(2) N/A(3) N/A(4) N/A(5) 02 December 2024(6) 02 December 2024(7) 02 December 2024
No. of securities held prior to change	(1) 2,000,000 - UNLISTED DIRECTOR OPT @$0.0375 EXP 01/12/2027(2) 1,000,000 - UNLISTED DIRECTOR OPT @$0.05 EXP 01/12/2027(3) 1,000,000 - UNLISTED DIRECTOR OPT @$0.075 EXP 01/12/2027(4) 2,000,000 - ORDINARY FULLY PAID SHARES(5) NIL - Dir AGM24 Opt $0.03 Vest 31/12/2024 Exp31/12/2027(6) NIL - Dir AGM24 Opt $0.04 Vest 31/12/2026 Exp31/12/2029(7) NIL - Dir AGM24 Opt $0.05 Vest 31/12/2027 Exp31/12/2030

• See chapter 19 for defined terms. 01/01/2011 Appendix 3Y Page 1

Appendix 3Y Change of Director's Interest Notice

	Appendix 3YChange of Director's Interest Notice
Class	(1) UNLISTED DIRECTOR OPT @ $0.0375 EXP01/12/2027(2) UNLISTED DIRECTOR OPT @ $0.05 EXP01/12/2027(3) UNLISTED DIRECTOR OPT @ $0.075 EXP01/12/2027(4) ORDINARY FULLY PAID SHARES(5) Dir AGM24 Opt $0.03 Vest 31/12/2024 Exp31/12/2027(6) Dir AGM24 Opt $0.04 Vest 31/12/2026 Exp31/12/2029(7) Dir AGM24 Opt $0.05 Vest 31/12/2027 Exp31/12/2030
Number acquired	(1) NIL(2) NIL(3) NIL(4) NIL(5) 2,000,000 - Dir AGM24 Opt $0.03 Vest31/12/2024 Exp 31/12/2027(6) 2,000,000 - Dir AGM24 Opt $0.04 Vest31/12/2026 Exp 31/12/2029(7) 5,000,000 - Dir AGM24 Opt $0.05 Vest31/12/2027 Exp 31/12/2030
Number disposed	N/A
Value/Consideration	(1) N/A(2) N/A(3) N/A(4) N/A(5) NIL(6) NIL(7) NIL
No. of securities held after change	(1) 2,000,000 - UNLISTED DIRECTOR OPT @$0.0375 EXP 01/12/2027(2) 1,000,000 - UNLISTED DIRECTOR OPT @$0.05 EXP 01/12/2027(3) 1,000,000 - UNLISTED DIRECTOR OPT @$0.075 EXP 01/12/2027(4) 2,000,000 - ORDINARY FULLY PAID SHARES(5) 2,000,000 - Dir AGM24 Opt $0.03 Vest31/12/2024 Exp 31/12/2027(6) 2,000,000 - Dir AGM24 Opt $0.04 Vest31/12/2026 Exp 31/12/2029(7) 5,000,000 - Dir AGM24 Opt $0.05 Vest31/12/2027 Exp 31/12/2030

• See chapter 19 for defined terms. 01/01/2011 Appendix 3Y Page 2

Appendix 3Y Change of Director's Interest Notice

	Appendix 3YChange of Director's Interest Notice
Nature of change	(1) N/A
	(2) N/A
	(3) N/A
	(4) N/A
	(5) ALLOTMENT OF DIRECTOR OPTIONS AS
	APPROVED BY SHAREHOLDERS ON 8
	NOVEMBER 2024
	(6) ALLOTMENT OF DIRECTOR OPTIONS AS
	APPROVED BY SHAREHOLDERS ON 8
	NOVEMBER 2024
	(7) ALLOTMENT OF DIRECTOR OPTIONS AS
	APPROVED BY SHAREHOLDERS ON 8
	NOVEMBER 2024

Part 2 - Change of director's relevant interests in contracts

Note: In the case of a company, interests which come within paragraph (ii) of the definition of "notifiable interest of a director" should be disclosed in this part.

Detail of contract	N/A
Nature of interest	N/A
Name of registered holder	N/A
(if issued securities)
Date of change	N/A
No. and class of securities	N/A
to which interest related
prior to change
Interest acquired	N/A
Interest disposed	N/A
Value/Consideration	N/A
Interest after change	N/A

Part 3 -[+] Closed period

Part 3 -+Closed period
Were the interests in the securities or	NO
contracts detailed above traded during a+closed period where prior written clearance
was required?
If so, was prior written clearance provided to	N/A
allow the trade to proceed during this period?
If prior written clearance was provided, on	N/A
what date was this provided?

• See chapter 19 for defined terms. 01/01/2011 Appendix 3Y Page 3